Methylbutyltryptamine
Names | |
---|---|
Preferred IUPAC name
N-[2-(1H-Indol-3-yl)ethyl]-N-methylpropan-1-amine | |
Other names
N-methyl-N-butyltryptamine | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
CompTox Dashboard (EPA) |
|
InChI
| |
SMILES
| |
Properties | |
Chemical formula |
C15H22N2 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
MBT, or N-methyl-N-butyltryptamine, is a lesser-known psychedelic drug. MBT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), the minimum dosage is listed as 250-400 mg, and the duration listed as 4–6 hours. MBT produces a heavy body load with dehydration, and causes visuals similar to those of DMT. Very little data exists about the pharmacological properties, metabolism, and toxicity of MBT.
MSBT
TiHKAL mentions that a structural isomer of MBT exists, with the butyl group attached at the nitrogen atom. It is known as N-s-butyl-N-methyltryptamine, or MSBT. However, little is known about its psychoactivity.
See also
External links
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.